FDAFDA · Food and drugs·Recall number D-0560-2025
Tirzepatide + Niacinamide 16.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 3 x 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.
Published August 13, 2025 · Recall initiated: July 18, 2025
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Processing Controls.
What to do
Voluntary: Firm initiated · E-Mail
Recall details
- Manufacturer
- AEQUITA PHARMACY
- Distributor
- MA
- Lot
- All Lots within expiry.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.